Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
22.01. | AFT Pharmaceuticals - Another R&D asset in the bag | 297 | Edison Investment Research | AFT Pharmaceuticals has announced the addition of another candidate, HY-091, to its R&D pipeline, for the management of vulvar lichen sclerosus (VLS), a skin condition with no curative treatments available.... ► Artikel lesen | |
22.01. | Accsys Technologies - Updating estimates for guidance and capital raise | 405 | Edison Investment Research | In September 2023, Accsys warned of weaker market conditions in the building materials and construction markets and in November, it stated not to expect trading conditions to improve materially until... ► Artikel lesen | |
22.01. | OSE Immunotherapeutics - Active year ahead for proprietary programmes | 351 | Edison Investment Research | OSE has refreshed its outlook for 2024, including the commencement of the confirmatory Phase III trial for lead asset Tedopi (an off-the-shelf, neoepitope-based cancer vaccine) in second-line non-small... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
NEL | 624 |
EVOTEC | 512 |
NVIDIA | 504 |
BIONTECH | 361 |
TUI | 317 |
BAYER | 315 |
VOLKSWAGEN | 250 |
GAMESTOP | 237 |
PLUG POWER | 230 |
RHEINMETALL | 213 |
BYD | 186 |
SALESFORCE | 153 |
DEUTSCHE LUFTHANSA | 133 |
BASF | 132 |
DELL TECHNOLOGIES | 130 |
AIXTRON SE | 126 |
MERCEDES-BENZ | 121 |
TESLA | 115 |
DEUTSCHE TELEKOM | 114 |
SUPER MICRO COMPUTER | 109 |
SIEMENS ENERGY | 107 |
DEUTSCHE BANK | 102 |
AMAZON | 96 |
BORUSSIA DORTMUND | 96 |
RWE | 95 |